| Primary |
| Drug Use For Unknown Indication |
46.2% |
| Dizziness |
23.1% |
| Product Used For Unknown Indication |
15.4% |
| Foetal Exposure During Pregnancy |
7.7% |
| Nausea |
7.7% |
|
| Drug Exposure During Pregnancy |
14.3% |
| Gastroschisis |
14.3% |
| Poor Quality Drug Administered |
14.3% |
| Fallot's Tetralogy |
7.1% |
| Limb Malformation |
7.1% |
| Medication Error |
7.1% |
| Overdose |
7.1% |
| Tachycardia |
7.1% |
| Toxic Epidermal Necrolysis |
7.1% |
| Ventricular Septal Defect |
7.1% |
| Vomiting |
7.1% |
|
| Secondary |
| Product Used For Unknown Indication |
24.7% |
| Prophylaxis Of Nausea And Vomiting |
14.1% |
| Prophylaxis |
8.1% |
| Drug Use For Unknown Indication |
5.3% |
| Pain |
4.9% |
| Neuroendocrine Carcinoma |
4.6% |
| Pneumocystis Jiroveci Pneumonia |
4.6% |
| Constipation |
3.5% |
| Intentional Overdose |
3.5% |
| Analgesic Therapy |
2.8% |
| Cholinergic Syndrome |
2.8% |
| Fungal Infection |
2.8% |
| Nausea |
2.5% |
| Suicide Attempt |
2.5% |
| Vomiting |
2.5% |
| Antifungal Prophylaxis |
2.1% |
| Cholangitis |
2.1% |
| Hypertension |
2.1% |
| Neuroblastoma |
2.1% |
| Prophylaxis Against Dehydration |
2.1% |
|
| Vomiting |
10.9% |
| Suicide Attempt |
8.7% |
| Thrombocytopenia |
8.7% |
| Toxic Epidermal Necrolysis |
8.7% |
| Ventricular Tachycardia |
8.7% |
| Anaphylactic Shock |
6.5% |
| Haematotoxicity |
4.3% |
| Intentional Overdose |
4.3% |
| Leukopenia |
4.3% |
| Multiple Drug Overdose Intentional |
4.3% |
| Neoplasm Progression |
4.3% |
| Somnolence |
4.3% |
| Substance Abuse |
4.3% |
| Toxicity To Various Agents |
4.3% |
| Anaemia |
2.2% |
| Completed Suicide |
2.2% |
| Death |
2.2% |
| Dehydration |
2.2% |
| Diarrhoea |
2.2% |
| Fungal Infection |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.8% |
| Product Used For Unknown Indication |
22.5% |
| Prophylaxis |
10.7% |
| Nausea |
5.7% |
| Hypertension |
4.1% |
| Pain |
4.0% |
| Constipation |
3.1% |
| Prophylaxis Of Nausea And Vomiting |
2.7% |
| Infection Prophylaxis |
2.4% |
| Depression |
2.2% |
| Acute Myeloid Leukaemia |
2.1% |
| Hiv Infection |
1.9% |
| Breast Cancer |
1.8% |
| Non-small Cell Lung Cancer |
1.7% |
| Multiple Myeloma |
1.6% |
| Insomnia |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Vomiting |
1.6% |
| Rheumatoid Arthritis |
1.5% |
| Diabetes Mellitus |
1.4% |
|
| Vomiting |
25.9% |
| Thrombocytopenia |
7.5% |
| Nausea |
5.7% |
| Renal Tubular Necrosis |
5.2% |
| Ventricular Tachycardia |
5.2% |
| Renal Failure Acute |
4.6% |
| Pyrexia |
4.0% |
| Ureteric Stenosis |
4.0% |
| Death |
3.4% |
| Necrotising Fasciitis |
3.4% |
| Pulmonary Embolism |
3.4% |
| Septic Shock |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Urinary Tract Infection |
3.4% |
| Bundle Branch Block Left |
2.9% |
| Hyponatraemia |
2.9% |
| Intestinal Obstruction |
2.9% |
| Pulmonary Oedema |
2.9% |
| Respiratory Failure |
2.9% |
| Silent Myocardial Infarction |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
70.0% |
| Prophylaxis Of Nausea And Vomiting |
10.0% |
| Thyroglossal Cyst Excision |
10.0% |
| Induction And Maintenance Of Anaesthesia |
6.7% |
| Induction Of Anaesthesia |
3.3% |
|
| Drug Interaction |
33.3% |
| Skin Discolouration |
33.3% |
| Ventricular Tachycardia |
33.3% |
|
